MedPath

Comparison of oral versus vaginal misoprostol for legal abortio

Phase 3
Conditions
Medical abortion.
termination of pregnancy
Registration Number
IRCT2014110812789N9
Lead Sponsor
Vice Chancellor for Research, Kurdistan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

pregnant women who are candidates of pregnancy termination with the permission of legal Medicine.
Exclusion criteria : pregnant women who are breastfeeding, women with severe liver disease, chronic pulmonary disease, Mitral valve stenosis, history of allergy to prostaglandins, inflammatory disease of intestines, asthma, glaucoma, hypertension, and severe bleeding.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy Exertion. Timepoint: Beginning of the study, every 6 hours up to 36 hours. Method of measurement: dilatation of cervix-contraction and hemorrhage.
Secondary Outcome Measures
NameTimeMethod
Fever. Timepoint: Every one hour until the last dosage. Method of measurement: Clinical Examination.;Uterus perforation. Timepoint: Every one hour until the last dosage. Method of measurement: Clinical examination by Gynecology resident.;Amount of bleeding. Timepoint: The start of the intervention up to 36 hours. Method of measurement: Observation and clinical examination.
© Copyright 2025. All Rights Reserved by MedPath